Brief: Portage Biotech Announces Letter Of Intent With Immunova For An Option To Acquire Iox Therapeutics
Dec 17 (Reuters) - Portage Biotech Inc PRTG.O :
* PORTAGE BIOTECH ANNOUNCES LETTER OF INTENT WITH IMMUNOVA
FOR AN
OPTION TO ACQUIRE IOX THERAPEUTICS, LTD
* PORTAGE BIOTECH INC - HAVE AGREED WITH IMMUNOVA TO
NEGOTIATE
ACQUISITION OF IOX THERAPEUTICS
Source text: ID:nGNX28Y9jt
Further company coverage: PRTG.O
Recent news on Alpha Compute
See all newsBrief: Alpha Compute Corp. Provides Mid-Q2 2026 Update
Brief: Alpha Compute Ai Gpu Launch Update First Large-Scale Nvidia Blackwell Cluster
Brief: Alpha Compute Appoints Tom Richer To Advisory Board To Accelerate Ai Gpu Compute Infrastructure And Confidential Cloud Strategy
Brief: Alphaton Capital Rebrands As Alpha Compute Corp. To Reflect Its Growing Ai Compute Business
Brief: Alphaton Capital Announces $43 Million Ai Infrastructure And Financing Partnership With Vertical Data